EDGAR Filing Documents for 0001193125-15-370611

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-15-370611

Filing Date

2015-11-09

Accepted

2015-11-06 21:38:22

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d59814ds3.htm	S-3	291879
2	EX-4.3	d59814dex43.htm	EX-4.3	281917
3	EX-4.5	d59814dex45.htm	EX-4.5	95721
4	EX-4.6	d59814dex46.htm	EX-4.6	94697
5	EX-4.7	d59814dex47.htm	EX-4.7	83235
6	EX-5.1	d59814dex51.htm	EX-5.1	24092
7	EX-12.1	d59814dex121.htm	EX-12.1	6658
8	EX-23.1	d59814dex231.htm	EX-23.1	1313
9	GRAPHIC	g59814g66o28.jpg	GRAPHIC	7825
10	GRAPHIC	g59814g84p01.jpg	GRAPHIC	10247
	Complete submission text file	0001193125-15-370611.txt		905598

Mailing Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080

Business Address 701 GATEWAY BLVD SUITE 200 SOUTH SAN FRANCISCO CA 94080 650-278-8930

Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)